RPRX · US market

ROYALTY PHARMA PLC CLASS A

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$32.09bnFinancials dated 30 June 2026Price dated 1 October 2026

Core valuation

Trailing P/E39.52×

Latest-quarter run-rate P/E448.67×

Trailing P/S12.66×

Latest-quarter run-rate P/S11.90×

Calculation inputs

Trailing earnings: US$812.00m
Latest-quarter run-rate earnings: US$71.53m
Latest fiscal-year earnings: US$770.95m
Trailing revenue: US$2.54bn
Latest-quarter run-rate revenue: US$2.70bn
Latest fiscal-year revenue: US$2.38bn

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

IHE · iShares U.S. Pharmaceuticals ETF4.39% weight · Holdings dated 21 August 2026
HRVIX · Heartland Value Plus Fund Investor Class3.22% weight · Holdings dated 30 June 2026
ELCV · Eventide High Dividend ETF3.19% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
IBBQ · Invesco Nasdaq Biotechnology ETF3.13% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
PBE · Invesco Biotechnology & Genome ETF3.13% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 162 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
OUSM · ALPS | OShares U.S. Small-Cap Quality Dividend ETF3.07% weight · Holdings dated 31 May 2026
THCRX · Thornburg Focus Growth Fund Class R32.91% weight · Holdings dated 30 June 2026
KMVAX · Kirr Marbach Partners Value Fund2.76% weight · Holdings dated 30 June 2026
AUIAX · AB Equity Income Fund Class A2.09% weight · Holdings dated 31 May 2026
GDOC · Goldman Sachs Future Health Care Equity ETF1.77% weight · Holdings dated 31 May 2026

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.